CD8A and neoplasm: These in situ vaccines exhibited compelling anti-tumor effects in a mouse xenograft model of triple negative breast cancer (TNBC), as well as in patient-derived organoids by stimulation of cDC1s and CD8+ T cell activity against tumor cells [105].